A Patient Friendly Corifollitropin Alfa Protocol without Routine Pituitary Suppression in Normal Responders

The release of corifollitropin alfa simplifies daily injections of short-acting recombinant follicular stimulating hormone (rFSH), and its widely-used protocol involves short-acting gonadotropins supplements and a fixed GnRH antagonist regimen, largely based on follicle size. In this study, the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huai-Ling, Lai, Hsing-Hua, Chuang, Tzu-Hsuan, Shih, Yu-Wei, Huang, Shih-Chieh, Lee, Meng-Ju, Chen, Shee-Uan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839605/
https://www.ncbi.nlm.nih.gov/pubmed/27100388
http://dx.doi.org/10.1371/journal.pone.0154123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839605/
https://www.ncbi.nlm.nih.gov/pubmed/27100388
http://dx.doi.org/10.1371/journal.pone.0154123

Ejemplares similares